Dr. Reddy's: Buy Rating Boosts Stock

  Published 10 months ago

Dr. Reddy's Laboratories stock is rising following a 'Buy' recommendation from Motilal Oswal. Their Conviction Delivery Idea sets a ₹1,316 target price, with a ₹1,215 stop loss, signaling positive investor sentiment.

  • Motilal Oswal initiates a 'Buy' call.
  • Target price set at ₹1,316.
  • Stop loss advised at ₹1,215.

You might like these

₹15,096 Cr Boost for Farmers

Vopak's AVTL IPO in India: A Success!

MCEI Shares Jump 2.5% to Six‑Week High

Kolte-Patil Stock Gains on Blackstone Stake Approval

JSW Steel Seeks Higher Met Coke Quota

THINK Gas Cuts Costs with ABB Tech

V-Mart Q1 Profit Soars 361% YoY

News that matters the most ⚡